These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 28867370)

  • 1. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
    Liu D; Li J; Cheng B; Wu Q; Pan H
    Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
    Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
    Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
    Luo Q; Zhao J; Zhang X; Pan W
    Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
    Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z
    Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
    Balguri SP; Adelli GR; Majumdar S
    Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.
    Tian B; Luo Q; Song S; Liu D; Pan H; Zhang W; He L; Ma S; Yang X; Pan W
    J Pharm Sci; 2012 Mar; 101(3):1040-9. PubMed ID: 22102480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition.
    Pai RV; Vavia PR
    Int J Pharm; 2020 Mar; 577():119095. PubMed ID: 32004680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
    Xu T; Zhang J; Chi H; Cao F
    Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
    Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
    Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
    Wang Y; Zhou L; Fang L; Cao F
    Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
    Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir.
    Seyfoddin A; Sherwin T; Patel DV; McGhee CN; Rupenthal ID; Taylor JA; Al-Kassas R
    Curr Drug Deliv; 2016; 13(6):923-34. PubMed ID: 26568139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Palmeira-de-Oliveira A; Lobo JM; Amaral MH
    Curr Drug Deliv; 2016; 13(6):953-70. PubMed ID: 26502890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.